Table 8.
Distribution of the different SAEs types for different age and sex groups.
Vaccine | Age and sex group | Deaths | Life threatening | Disabilities | Hospitalizations |
---|---|---|---|---|---|
COVID-19 | All 12–49 | 0.0378 | 0.1710 | 0.2120 | 0.5792 |
Males 12–49 | 0.0509 | 0.1681 | 0.1845 | 0.5965 | |
Females 12–49 | 0.0279 | 0.1733 | 0.2329 | 0.5659 | |
Adolescents 12–17 | 0.0198 | 0.1435 | 0.0885 | 0.7481 | |
Males 12–17 | 0.0134 | 0.1405 | 0.0649 | 0.7813 | |
Females 12–17 | 0.0322 | 0.1495 | 0.1340 | 0.6843 | |
Adults 18–49 | 0.0394 | 0.1735 | 0.2230 | 0.5640 | |
Males 18–49 | 0.0563 | 0.1722 | 0.2015 | 0.5700 | |
Females 18–49 | 0.0277 | 0.1745 | 0.2381 | 0.5597 | |
Influenza | All 13–49 | 0.0298 | 0.1942 | 0.1909 | 0.5851 |
Males, 13–49 | 0.0397 | 0.1857 | 0.1647 | 0.6098 | |
Females, 13–49 | 0.0242 | 0.1989 | 0.2055 | 0.5713 | |
Adolescents 13–17 | 0.0431 | 0.2000 | 0.1294 | 0.6274 | |
Males 13–17 | 0.0254 | 0.1949 | 0.1441 | 0.6356 | |
Females 13–17 | 0.0584 | 0.2044 | 0.1168 | 0.6204 | |
Adults 18–49 | 0.0286 | 0.1936 | 0.1983 | 0.5795 | |
Males 18–49 | 0.0420 | 0.1843 | 0.1680 | 0.6057 | |
Females 18–49 | 0.0215 | 0.1986 | 0.2143 | 0.5656 | |
HPV | All 13–17 | 0.0529 | 0.1614 | 0.2859 | 0.4997 |
Males 13–17 | 0.0465 | 0.1744 | 0.1938 | 0.5853 | |
Females 13–17 | 0.0539 | 0.1594 | 0.2999 | 0.4867 | |
Monkeypox | Males 18–49 | 0.1250 | 0.2500 | 0 | 0.6250 |